Repositori institucional URV
Español Català English
TITLE:
Tryptophanol-derived oxazolopiperidone lactams: Identification of a hit compound as NMDA receptor antagonist - PC:981

URV's Author/s:Nuno A. L. Pereira, Francesc X. Sureda, Roser Esplugas, Maria Pérez, Mercedes Amat and Maria M. M. Santos
Author, as appears in the article.:Pereira, N.A.L.
Sureda, F.X.
Esplugas, R.
Pérez, M.
Amat, M.
Santos, M.M.M.
Journal publication year:2014
ISSN:0960-894X
e-ISSN:1464-3405
Abstract:N-Methyl-d-aspartate receptors (NMDAR) exacerbated activation leads to neuron death through a phenomenon called excitotoxicity. These receptors are implicated in several neurological diseases (e.g., Alzheimer and Parkinson) and thus represent an important therapeutic target. We herein describe the study of enantiopure tryptophanol-derived oxazolopiperidone lactams as NMDA receptor antagonists. The most active hit exhibited an IC50 of 63.4 µM in cultured rat cerebellar granule neurons thus being 1.5 fold more active than clinically approved NMDA antagonist amantadine (IC50 = 92 µM)
Article's DOI:https://doi.org/10.1016/j.bmcl.2014.05.105
Link to the original source:http://www.sciencedirect.com/science/article/pii/S0960894X14006349
Papper version:info:eu-repo/semantics/submittedVersion
licence for use:https://creativecommons.org/licenses/by/3.0/es/
Department:Ciències Mèdiques Bàsiques
Licence document URL:https://repositori.urv.cat/ca/proteccio-de-dades/
Keyword in other language:Amantadine
lactam
tryptophanol derived oxazolopiperidone lactam derivative
unclassified drug
degenerative disease
Entity:Universitat Rovira i Virgili.
First page:3333
Last page:3336
Journal volume:24
Search your record at:

Available files
FileDescriptionFormat
DocumentPrincipalDocumentPrincipalapplication/pdf

Information

© 2011 Universitat Rovira i Virgili